Mammoth Biosciences Funding: $465M Raised, Series D (2021)
Mammoth Biosciences is a Biotech company based in Brisbane, CA. It has raised $465M in total funding. Latest round: Series D.
Mammoth Biosciences funding overview
Mammoth Biosciences is a Biotech company based in Brisbane, CA. Mammoth Biosciences has raised $465M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in January 2021. The round record for Mammoth Biosciences runs through 2021; nothing later has been disclosed. Investors on record include Redmile Group, Foresite Capital, Senator Investment Group, Sixth Street, Greenspring Associates, Mayfield and 3 others. 9 distinct backers are named across the disclosed rounds.
Frequently asked about Mammoth Biosciences funding
How much has Mammoth Biosciences raised?
Mammoth Biosciences has raised $465M in total disclosed funding across the rounds on record.
Who has invested in Mammoth Biosciences?
Redmile Group, Foresite Capital, Senator Investment Group, Sixth Street, Greenspring Associates, Mayfield are named among the investors backing Mammoth Biosciences.
What was the latest Mammoth Biosciences funding round?
The most recent disclosed round is a Series D, announced in January 2021.
Where is Mammoth Biosciences based?
Mammoth Biosciences is based in Brisbane, CA.
What sector does Mammoth Biosciences operate in?
Mammoth Biosciences is tracked under Biotech from Brisbane, CA, with $465M in disclosed funding.
When did Mammoth Biosciences last raise?
The last disclosed Mammoth Biosciences round closed in January 2021 at Series D.
Mammoth Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Brisbane below to benchmark round size and investor mix.
